These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 16003178

  • 1. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY.
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [Abstract] [Full Text] [Related]

  • 2. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY.
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [Abstract] [Full Text] [Related]

  • 3. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY.
    Circulation; 2002 Mar 05; 105(9):1122-7. PubMed ID: 11877366
    [Abstract] [Full Text] [Related]

  • 4. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY.
    Hypertension; 2001 Feb 05; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [Abstract] [Full Text] [Related]

  • 5. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV, Lakatta EG, Bagrov AY.
    Circulation; 2000 Dec 12; 102(24):3009-14. PubMed ID: 11113054
    [Abstract] [Full Text] [Related]

  • 6. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
    Bagrov AY, Agalakova NI, Kashkin VA, Fedorova OV.
    Am J Hypertens; 2009 May 12; 22(5):559-63. PubMed ID: 19229192
    [Abstract] [Full Text] [Related]

  • 7. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
    Anderson DE, Fedorova OV, Morrell CH, Longo DL, Kashkin VA, Metzler JD, Bagrov AY, Lakatta EG.
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr 12; 294(4):R1248-54. PubMed ID: 18287222
    [Abstract] [Full Text] [Related]

  • 8. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake.
    Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG, Bagrov AY.
    J Hypertens; 2005 Apr 12; 23(4):835-42. PubMed ID: 15775789
    [Abstract] [Full Text] [Related]

  • 9. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY.
    J Hypertens; 2004 Feb 12; 22(2):389-97. PubMed ID: 15076199
    [Abstract] [Full Text] [Related]

  • 10. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix MT, Lakatta EG, Bagrov AY.
    Hypertension; 2003 Mar 12; 41(3):505-11. PubMed ID: 12623951
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky A, Reznik VA, Frolova EV, Nikitina ER, Budny GV, Longo DL, Lakatta EG, Bagrov AY.
    J Hypertens; 2008 Dec 12; 26(12):2414-25. PubMed ID: 19008721
    [Abstract] [Full Text] [Related]

  • 12. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension.
    Bagrov AY, Fedorova OV.
    Front Biosci; 2005 Sep 01; 10():2250-6. PubMed ID: 15970491
    [Abstract] [Full Text] [Related]

  • 13. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump.
    Fedorova OV, Kashkin VA, Zakharova IO, Lakatta EG, Bagrov AY.
    J Hypertens; 2012 Sep 01; 30(9):1817-26. PubMed ID: 22796708
    [Abstract] [Full Text] [Related]

  • 14. Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats.
    Kashkin VA, Zvartau EE, Fedorova OV, Bagrov YY, Lakatta EG, Bagrov AY.
    Eur Neuropsychopharmacol; 2008 Jan 01; 18(1):74-7. PubMed ID: 17683916
    [Abstract] [Full Text] [Related]

  • 15. Endogenous cardiotonic steroids in chronic renal failure.
    Kolmakova EV, Haller ST, Kennedy DJ, Isachkina AN, Budny GV, Frolova EV, Piecha G, Nikitina ER, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY.
    Nephrol Dial Transplant; 2011 Sep 01; 26(9):2912-9. PubMed ID: 21292813
    [Abstract] [Full Text] [Related]

  • 16. Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.
    Fedorova OV, Fadeev AV, Grigorova YN, Marshall CA, Zernetkina V, Kolodkin NI, Agalakova NI, Konradi AO, Lakatta EG, Bagrov AY.
    J Cardiovasc Pharmacol; 2019 Nov 01; 74(5):436-442. PubMed ID: 31415452
    [Abstract] [Full Text] [Related]

  • 17. Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.
    Fedorova OV, Lakatta EG, Bagrov AY, Melander O.
    J Hypertens; 2015 Mar 01; 33(3):534-41; discussion 541. PubMed ID: 25479026
    [Abstract] [Full Text] [Related]

  • 18. [The role of Na+-K+ ATPase activity on blood pressure regulation and sodium metabolism in DOCA-treated rats].
    Shigetomi S, Tosaki H, Ueno S, Kohno H, Mori K, Katoh K, Tanaka K, Haga H, Kin S, Matsunaga A.
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct 20; 65(10):1198-207. PubMed ID: 2556303
    [Abstract] [Full Text] [Related]

  • 19. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY.
    J Hypertens; 1999 Aug 20; 17(8):1179-87. PubMed ID: 10466474
    [Abstract] [Full Text] [Related]

  • 20. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.
    Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, Bagrov AY.
    Front Biosci; 2005 Sep 01; 10():2257-62. PubMed ID: 15970492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.